(Q36804493)

16 August 2017

1 reference

title

Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis (English)

1 reference

16 August 2017

0 references

Shinya Mizuno

1

1 reference

16 August 2017

Toshikazu Nakamura

series ordinal

2

1 reference

16 August 2017

language of work or name

1 reference

1 March 2007

1 reference

16 August 2017

published in

Regenerative Medicine

1 reference

16 August 2017

volume

2

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

161-170

1 reference

Management of cirrhosis and ascites

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Hepatocyte growth factor: from diagnosis to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Scatter factor/hepatocyte growth factor is essential for liver development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Purification and subunit structure of hepatocyte growth factor from rat platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Possible endocrine control by Hepatocyte Growth Factor of liver regeneration after partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

A mechanism of cell survival: sequestration of Fas by the HGF receptor Met.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Impairment of activation of hepatocyte growth factor precursor into its mature form in rats with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Suppression of transforming growth factor-beta results in upregulation of transcription of regeneration factors after chronic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Significance of branched chain amino acids as possible stimulators of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Administration of rhHGF-activator via portal vein stimulates the regeneration of cirrhotic liver after partial hepatectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Effects of deletion variant of hepatocyte growth factor on reduced-size liver transplantation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.2.2.161

21 January 2018

Identifiers

DOI

10.2217/17460751.2.2.161

1 reference

16 August 2017

1 reference